Coram Clinical Trials, Inc. – Indentures – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Indentures Filter

from S-4 25 pages Registration Rights Agreement by and Among Apria Healthcare Group Inc., the Guarantors Named Herein and Banc of America Securities LLC Wells Fargo Securities, LLC Barclays Capital Inc. and Scotia Capital (USA) Inc. Dated as of August 13, 2009

from S-4 25 pages Registration Rights Agreement by and Among Apria Healthcare Group Inc., the Guarantors Named Herein and Banc of America Securities LLC Wachovia Capital Markets, LLC Barclays Capital Inc. and Scotia Capital (USA) Inc. Dated as of May 27, 2009

from S-4 7 pages Second Supplemental Indenture (This “Supplemental Indenture”), Dated as of July 13, 2010 Among Ahny-Dme LLC and Ahny-IV LLC (Each, a “Guaranteeing Subsidiary” and Collectively, the “Guaranteeing Subsidiaries”), Subsidiaries of Apria Healthcare Group Inc., a Delaware Corporation (The “Company”), and U.S. Bank National Association, as Trustee (The “Trustee”)

from S-4 7 pages Supplemental Indenture for the Issuance of the Series A-2 Notes

from S-4 190 pages Indenture Dated as of May 27, 2009 Among Apria Healthcare Group Inc., the Guarantors Named on the Signature Pages Hereto, and U.S. Bank National Association, as Trustee 11.25% Senior Secured Notes Due 2014 (Series A-1) Senior Secured Notes Due 2014